# Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

> **NCT00107081** · PHASE3 · TERMINATED · sponsor: **Swiss Pediatric Oncology Group** · enrollment: 70 (actual)

## Conditions studied

- Fever
- Neutropenia
- Cancer

## Interventions

- **DRUG:** ciprofloxacin and amoxicillin
- **PROCEDURE:** Outpatient management
- **DRUG:** i.v. antibiotics
- **PROCEDURE:** inpatient management

## Key facts

- **NCT ID:** NCT00107081
- **Lead sponsor:** Swiss Pediatric Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** Accrual goal for interventional part not achievable
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107081, "Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00107081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*